floatz AI

AI-powered platform for drug discovery, identifying high-potential therapeutic targets with precision.

Visit Site

AI Healthcare AI Research Tool AI For Data Analytics AI Report Generator AI Predictions

About floatz AI

floatz AI accelerates drug discovery by identifying promising targets based on human genetics, gene expression, and biological pathways. It integrates diverse data sources to map billions of concepts, enabling the rapid prioritization of targets with high translational potential. The platform delivers three clinically-relevant targets within 14 days, supporting efficient therapeutic development.

How to Use

Define your therapeutic focus, such as disease area, indication, and specific constraints. floatz analyzes literature, disease biology, omics data, and pathway networks to generate a comprehensive opportunity map. It then curates three top targets with scientific rationale, supporting data, and expert review, delivering a decision-ready PDF within 14 days.

Features

Comprehensive multi-source analysis including literature, omics, and pathway data

Rapid delivery of three clinically-relevant targets within 14 days

AI-enabled identification of drug targets

Integration of genetics, tissue expression, and pathway insights

Expert-reviewed and validated target selection

Use Cases

Guiding strategic decisions and licensing evaluations in drug development

Discovering novel therapeutic targets for specific diseases

Expanding existing drug pipelines or exploring new treatment areas

Best For

Early-stage biotech companiesResearch and development teamsInnovation-focused pharmaceutical firmsBiotech investment groupsAcademic research labs

Pros

Satisfaction guarantee with credit toward revisions

Full refund if not delivered within 14 days

Twice as fast as internal review processes

Exclusive access to generated targets

High-confidence, ready-to-advance targets

Data-driven approach eliminates guesswork

Customizable constraints such as modality or target class

Confidential, client-specific reports

Targets grounded in robust, multi-layered data

Cons

Pricing details are not publicly disclosed

Deliverables are in PDF format, not an interactive platform

Frequently Asked Questions

Find answers to common questions about floatz AI

Who benefits most from this platform?

Early-stage biotech companies, R&D teams, and innovation groups seeking novel targets without lengthy internal research.

How are the targets identified and selected?

We analyze literature, disease biology, omics data, and competitive intelligence, then filter for relevance, novelty, and druggability, with final validation by experts.

Is my project information kept confidential?

Absolutely. We do not share or reuse your disease focus or brief content. All reports are exclusively client-specific.

What if I am not satisfied with the deliverable?

If the brief does not meet your expectations, your payment can be applied to a revised version.

Will I have exclusive access to the targets?

Yes. Each brief is tailored for your project and not shared or reused. Targets are not recycled or resold.

What does the brief include?

A curated list of three targets with detailed rationale, references, and insights into their novelty and druggability, delivered as a comprehensive PDF.

How long does the process take?

Delivery occurs within 14 days after scope confirmation. If we cannot meet the timeline, you are not charged.

Can I specify constraints like target modality?

Yes, we accommodate specific constraints to align with your pipeline and platform needs.

Is it possible to discuss my project before placing an order?

Certainly. Feel free to contact us to align on your project details before submitting a request.